AN UNBIASED VIEW OF AGO TUMOR

Molecular typing relies on molecular genetic testing and isn't nevertheless routinely obtainable. Molecular subtypes and immunohistochemical surrogate markers in the tumors (HR, HER2, triple unfavorable) correlate in about 70%. The differentiation of luminal A and B subtypes by HR status and proliferation markers like Ki-sixty seven could be valuab